March 25, 2020
1:00 – 2:00 PM ET
Register here.
The last few years have seen a dramatic rise in the number of securities class-action cases involving initial public offerings, and this has affected D&O coverage and the costs associated with D&O insurance.
During this webcast, Mike Ferraro and Yelena Dunaevsky from Woodruff Sawyer…
February 21, 2020
1:00 – 2:00 PM ET
Click here to register
The U.S. capital markets remain an attractive source of capital for emerging companies in the life sciences sector. Life sciences continued to represent the most significant percentage by deal volume of IPO activity in 2019. Many of these IPOs were preceded by late…
Thursday, February 27, 2020
Seton Hall University School of Law
8:30 a.m. – 9:00 a.m. Registration
9:00 a.m. – 3:30 p.m. Program
Please visit the event website to register.
We invite you to attend the Hot Topics in Life Sciences Law symposium, presented by Mayer Brown and the Center for Health & Pharmaceutical Law &…
Date: December 2, 2019
Time: 1:00pm – 2:00pm ET
Speakers: Polia A. Nair, Ernst & Young LLP & Anna Pinedo, Mayer Brown LLP
During this webcast, we will review the overall areas of focus identified by the SEC staff for public companies, the disclosure issues that members of the SEC staff have…
In a recent briefing, CB Insights reported increased funding in the healthcare sector for the first half of 2019 with $26.9 billion invested in healthcare companies across 2,258 deals globally. While promising, funding for full year 2019 is not projected to surpass the $58.5 billion raised by healthcare companies in 2018. The number of late-stage…
Thursday, March 7, 2019
1:00 p.m. – 2:00 p.m. ET
During this webcast, we will review the overall areas of focus identified by the SEC Staff for public companies, the disclosure issues that members of the SEC Staff have highlighted as important for upcoming annual reports on Form 10-K and Form 20-F, and discuss the…
Thursday, March 7, 2019
1:00 p.m. – 2:00 p.m. ET
During this webcast, we will review the overall areas of focus identified by the SEC Staff for public companies, the disclosure issues that members of the SEC Staff have highlighted as important for upcoming annual reports on Form 10-K and Form 20-F, and discuss the…
We use cookies to enhance your experience of our websites and to enable you to register when necessary. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our Cookie Policy and our Privacy Notice.
